Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMEND-preserved
NCT05887271Phase 3Completed
- Sponsor
- University of Leicester
- Start
- Dec 2023
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in heart failure with preserved ejection fraction (HFpEF) and obesity (2 arms), sponsored by University of Leicester. Primary endpoint: 6-Minute Walk Test Distance at 24 weeks. Started Dec 2023; status: completed.
02
Conditions
heart failure with preserved ejection fraction (HFpEF)obesity
Beyond the preview
Go deeper on NCT05887271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05887271.